Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MEGI
4726
MainStay CBRE Global Infrastructure Megatrends Term Fund
MEGI
$787M
| $734K | ﹤0.01% |
+50,000
| New | +$717K |
|
4727
Arcturus Therapeutics
ARCT
$427M
| $734K | ﹤0.01% |
+39,800
| New | +$639K |
|
4728
CALL
Wave Life Sciences
WVE
$1.04B
| $732K | ﹤0.01% |
+100,000
| New | +$809K |
|
4729
Stem
STEM
$54.2M
| $732K | ﹤0.01% |
41,769
-37,843
| -48% | -$535K |
|
|
EDD
4730
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$381M
| $732K | ﹤0.01% |
+136,000
| New | +$720K |
|
4731
PUT
Shake Shack
SHAK
$2.96B
| $730K | ﹤0.01% |
7,800
-4,300
| -36% | -$494K |
|
4732
Chemung Financial Corp
CHMG
$394M
| $729K | ﹤0.01% |
13,886
+6,346
| +84% | +$331K |
|
|
FSFG
4733
DELISTED
First Savings Financial Group
FSFG
| $729K | ﹤0.01% |
23,203
-8,687
| -27% | -$233K |
|
4734
First Community Bankshares
FCBC
$927M
| $726K | ﹤0.01% |
20,859
-6,315
| -23% | -$239K |
|
4735
CALL
Opendoor
OPEN
$3.33B
| $725K | ﹤0.01% |
+94,033
| New | +$381K |
|
4736
Beam Therapeutics
BEAM
$3.12B
| $722K | ﹤0.01% |
29,750
-28,454
| -49% | -$566K |
|
4737
PUT
Taysha Gene Therapies
TSHA
$1.94B
| $719K | ﹤0.01% |
+220,000
| New | +$623K |
|
|
SRG
4738
Seritage Growth Properties
SRG
$119M
| $718K | ﹤0.01% |
168,839
-31,060
| -16% | -$109K |
|
4739
CALL
OneMain Financial
OMF
$7.28B
| $717K | ﹤0.01% |
12,700
-3,100
| -20% | -$183K |
|
4740
PUT
Rigetti Computing
RGTI
$5.38B
| $715K | ﹤0.01% |
24,000
-24,000
| -50% | -$421K |
|
4741
CVB Financial
CVBF
$3.95B
| $713K | ﹤0.01% |
37,689
-11,070
| -23% | -$220K |
|
|
BLFY
4742
DELISTED
Blue Foundry Bancorp
BLFY
| $713K | ﹤0.01% |
78,395
-4,866
| -6% | -$44.7K |
|
4743
CALL
Quantum Computing Inc
QUBT
$1.89B
| $709K | ﹤0.01% |
+38,500
| New | +$661K |
|
|
NVX
4744
NOVONIX
NVX
$104M
| $709K | ﹤0.01% |
553,564
-2,720
| -0.5% | -$3.55K |
|
4745
Clover Health Investments
CLOV
$2.23B
| $707K | ﹤0.01% |
231,166
-827,049
| -78% | -$2.36M |
|
4746
BioLife Solutions
BLFS
$1.82B
| $707K | ﹤0.01% |
27,698
+783
| +3% | +$18.6K |
|
4747
CALL
Omnicom Group
OMC
$23.8B
| $701K | ﹤0.01% |
+8,600
| New | +$649K |
|
4748
PUT
Hertz
HTZ
$759M
| $700K | ﹤0.01% |
103,000
-2,200,000
| -96% | -$14.1M |
|
4749
PUT
Semtech
SMTC
$12.8B
| $700K | ﹤0.01% |
9,800
-900
| -8% | -$48.9K |
|
4750
PUT
Canadian Pacific Kansas City
CP
$83.4B
| $700K | ﹤0.01% |
9,400
-41,500
| -82% | -$3.17M |
|
Similar funds
Israel Englander's Q3 2025 Portfolio in Review
As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
- Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Israel Englander opened 800 new positions and closed 633 in Q3 2025.
- Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.